So far, “the only established risk factors for prostate cancer are advancing age, African ancestry, and a family history of ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of ...

Sir Chris Hoy’s stage-four diagnosis has put prostate cancer under the spotlight among cyclists. Cycling Weekly tackles the ...

Lower urinary tract symptoms are not associated with an increased risk for high-grade prostate cancer, rendering biopsies and ...

Former President Joe Biden has been diagnosed with "aggressive" prostate cancer, his office said. It's relatively easy to treat if caught early, but symptoms often don't show up until it's advanced.

Scientists at the University of Edinburgh have used artificial intelligence to identify negative side effects of ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of international research on androgen deprivation therapy (ADT) for prostate cancer ...

Keir Starmer and his government have expressed a commitment to earlier cancer diagnosis and treatment as part of a 10-year ...

Treatments for prostate cancers localised to the prostate have long been aimed at treating the whole prostate either by ...